Skip to main content
. 2018 Jan 15;15(3):3447–3452. doi: 10.3892/ol.2018.7799

Table I.

Eighty cases of acute myeloid leukemia patients and 20 cases of normal blood index (mean ± standard deviation).

Group No. of cases (N) Hemoglobin (g/l) Red blood cell count (1×1012/l) Platelet count (1×109/l) Leucocyte count (1×109/l) Lymphocyte absolute value (1×109/l) Absolute value of mononuclear cells (1×109/l) Neutrophil absolute value (1×109/l)
Primary untreated 20 9.7±4.64 3.5±6.4 101.2±23.5 15.4±8.6 10.2±2.5 0.92±0.75 8.74±3.26
Complete remission 20 12.7±2.4 4.2±2.1 185.7±12.6 7.3±2.4 4.6±3.1 0.54±0.22 4.37±1.25
Incomplete remission 21 10.7±1.4 4.3±1.7 199.4±21.7 10.4±1.4 9.8±1.3 0.82±0.33 6.27±2.14
Relapse after remission 19 9.7±10.9 4.8±1.6 190.4±28.3 9.8±2.1 9.6±2.7 0.87±0.21 8.26±1.06
Control group 20 11.8±3.5 5.0±1.5 201.4±23.9 6.8±3.6 5.5±3.3 0.48±0.73 4.22±0.89
F value 0.86 0.97 0.97 2.24 1.02 1.22 1.05
P-value >0.05 >0.05 >0.05 <0.05 <0.05 <0.05 <0.05

There was no significant difference in the hemoglobin, red blood cell count and platelet count of the primary untreated group, incomplete remission group, and relapse after remission group (P>0.05).